世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の生物学的製剤製造市場 2018-2022年

Global Biologics Manufacturing Market 2018-2022

IRTNTR23716

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年8月US$2,500
シングルユーザライセンス
114

サマリー

この調査レポートは世界の生物学的製剤製造市場を分析・予測したTechNavioの市場調査報告書です。

Description

About Biologics
Biologics, biopharmaceutical, biologic drugs, or biological drugs refer to drugs that are extracted, synthesized, and manufactured from biological material derived from living sources, such as humans, plants, and animals. Biologics manufacturing refers to the production of such drugs.
Technavio’s analysts forecast the Global Biologics Manufacturing Market to grow at a CAGR of 9.11% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the biologics manufacturing market. To calculate the market size, the report considers the cost incurred for in-house manufacturing of biologics and the revenue generated by contract manufacturers of biologics across the globe.

The market is divided into the following segments based on geography:
? Americas
? APAC
? EMEA

Technavio's report, biologics manufacturing market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
? Amgen
? F. Hoffmann-La Roche
? Johnson & Johnson
? Merck & Co
? Pfizer
Market driver
? Introduction of new biologic drugs for treating diseases
? For a full, detailed list, view our report

Market challenge
? High cost of branded drugs is deterring market growth
? For a full, detailed list, view our report

Market trend
? Rise in partnerships between traditional biopharma companies and biotechnology startups
? For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors-

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
? Market ecosystem
? Market characteristics
? Market segmentation analysis
PART 05: MARKET SIZING
? Market definition
? Market sizing 2017
? Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
? Bargaining power of buyers
? Bargaining power of suppliers
? Threat of new entrants
? Threat of substitutes
? Threat of rivalry
? Market condition
PART 07: MARKET SEGMENTATION BY TECHNOLOGY
? Segmentation by technology
? Comparison by technology
? In-house - Market size and forecast 2017-2022
? Outsourced - Market size and forecast 2017-2022
? Market opportunity by technology
PART 08: MARKET SEGMENTATION BY PRODUCT
? Segmentation by product
? Comparison by product
? Biologics - Market size and forecast 2017-2022
? Biosimilars - Market size and forecast 2017-2022
? Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
? Geographical segmentation
? Regional comparison
? Americas - Market size and forecast 2017-2022
? EMEA - Market size and forecast 2017-2022
? APAC - Market size and forecast 2017-2022
? Key leading countries
? Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
? Market drivers
? Market challenges
PART 13: MARKET TRENDS
? Rise in partnerships between traditional biopharma companies and biotechnology startups
? Growing outsourcing of biologics manufacturing
? Increase in FDA approvals for new biologics products
PART 14: VENDOR LANDSCAPE
? Overview
? Landscape disruption
? Competitive scenario
PART 15: VENDOR ANALYSIS
? Vendors covered
? Vendor classification
? Market positioning of vendors
? Amgen
? F. Hoffmann-La Roche
? Johnson & Johnson
? Merck & Co.
? Pfizer
PART 16: APPENDIX
? List of abbreviations



Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global - Market size and forecast 2017-2022 ($ bn)
Exhibit 08: Global - Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Technology - Market share 2017-2022 (%)
Exhibit 18: Comparison by technology
Exhibit 19: In-house - Market size and forecast 2017-2022 ($ bn)
Exhibit 20: In-house - Year-over-year growth 2018-2022 (%)
Exhibit 21: Outsourced - Market size and forecast 2017-2022 ($ bn)
Exhibit 22: Outsourced - Year-over-year growth 2018-2022 (%)
Exhibit 23: Market opportunity by technology
Exhibit 24: Product - Market share 2017-2022 (%)
Exhibit 25: Comparison by product
Exhibit 26: Biologics - Market size and forecast 2017-2022 ($ bn)
Exhibit 27: Biologics - Year-over-year growth 2018-2022 (%)
Exhibit 28: Biosimilars - Market size and forecast 2017-2022 ($ bn)
Exhibit 29: Biosimilars - Year-over-year growth 2018-2022 (%)
Exhibit 30: Market opportunity by product
Exhibit 31: Customer landscape
Exhibit 32: Global - Market share by geography 2017-2022 (%)
Exhibit 33: Regional comparison
Exhibit 34: Americas - Market size and forecast 2017-2022 ($ bn)
Exhibit 35: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 36: EMEA - Market size and forecast 2017-2022 ($ bn)
Exhibit 37: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 38: APAC - Market size and forecast 2017-2022 ($ bn)
Exhibit 39: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Amgen: Overview
Exhibit 48: Amgen - Business segments
Exhibit 49: Amgen - Organizational developments
Exhibit 50: Amgen - Geographic focus
Exhibit 51: Amgen - Key offerings
Exhibit 52: F. Hoffmann-La Roche: Overview
Exhibit 53: F. Hoffmann-La Roche? Business segments
Exhibit 54: F. Hoffmann-La Roche - Organizational developments
Exhibit 55: F. Hoffmann-La Roche? Geographic focus
Exhibit 56: F. Hoffmann-La Roche? Segment focus
Exhibit 57: F. Hoffmann-La Roche - Key offerings
Exhibit 58: Johnson & Johnson: Overview
Exhibit 59: Johnson & Johnson? Business segments
Exhibit 60: Johnson & Johnson - Organizational developments
Exhibit 61: Johnson & Johnson - Geographic focus
Exhibit 62: Johnson & Johnson - Segment focus
Exhibit 63: Johnson & Johnson - Key offerings
Exhibit 64: Merck & Co.: Overview
Exhibit 65: Merck & Co. - Business segments
Exhibit 66: Merck & Co. - Organizational developments
Exhibit 67: Merck & Co. - Geographic focus
Exhibit 68: Merck & Co. - Segment focus
Exhibit 69: Merck & Co. - Key offerings
Exhibit 70: Pfizer: Overview
Exhibit 71: Pfizer - Business segments
Exhibit 72: Pfizer - Organizational developments
Exhibit 73: Pfizer - Geographic focus
Exhibit 74: Pfizer - Segment focus
Exhibit 75: Pfizer - Key offerings

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る